These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7685934

  • 21. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1755-60. PubMed ID: 9422416
    [Abstract] [Full Text] [Related]

  • 22. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 23. The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.
    Gjertson DW, Cecka JM, Terasaki PI.
    Transplantation; 1995 Dec 27; 60(12):1384-8. PubMed ID: 8545861
    [Abstract] [Full Text] [Related]

  • 24. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
    Franz M, Regele H, Schmaldienst S, Stummvoll HK, Hörl WH, Pohanka E.
    Transplantation; 1998 Nov 15; 66(9):1258-62. PubMed ID: 9825827
    [Abstract] [Full Text] [Related]

  • 25. Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution.
    Youngelman DF, Kahng KU, Rosen BD, Dresner LS, Wait RB.
    Transplantation; 1991 Feb 15; 51(2):503-9. PubMed ID: 1994546
    [Abstract] [Full Text] [Related]

  • 26. A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation.
    McDiarmid SV, Colonna JO, Shaked A, Ament ME, Busuttil RW.
    Transplantation; 1993 Oct 15; 56(4):847-53. PubMed ID: 7692636
    [Abstract] [Full Text] [Related]

  • 27. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
    Gossmann J, Radounikli A, Bernemann A, Schellinski O, Raab HP, Bickeböller R, Scheuermann EH.
    Kidney Blood Press Res; 2001 Oct 15; 24(2):111-5. PubMed ID: 11435743
    [Abstract] [Full Text] [Related]

  • 28. Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506).
    Canzanello VJ, Textor SC, Taler SJ, Schwartz LL, Porayko MK, Wiesner RH, Krom RA.
    Liver Transpl Surg; 1998 Jul 15; 4(4):328-34. PubMed ID: 9649648
    [Abstract] [Full Text] [Related]

  • 29. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 30. Renal hemodynamics in renal transplant recipients. The role of reduced kidney mass and cyclosporine administration.
    Pluvio C, DePascale E, Pluvio M, Carone M, Giordano M, Luzi L, Sabella F, Castellino P.
    Transplantation; 1996 Mar 15; 61(5):733-8. PubMed ID: 8607176
    [Abstract] [Full Text] [Related]

  • 31. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 15; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 32. Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients.
    Schrama YC, Joles JA, van Tol A, Boer P, Koomans HA, Hené RJ.
    Transplantation; 2000 Feb 15; 69(3):376-83. PubMed ID: 10706046
    [Abstract] [Full Text] [Related]

  • 33. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G.
    Kidney Int; 1999 Feb 15; 55(2):674-85. PubMed ID: 9987092
    [Abstract] [Full Text] [Related]

  • 34. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
    Bennett WM, Carpenter CB, Shapiro ME, Strom TB, Hefty D, Tillman M, Abrams J, Ryan D, Kelley VR.
    Transplantation; 1995 Feb 15; 59(3):352-6. PubMed ID: 7871564
    [Abstract] [Full Text] [Related]

  • 35. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK, Sørensen SS, Hansen HE, Pedersen EB.
    Nephrol Dial Transplant; 1998 Sep 15; 13(9):2327-34. PubMed ID: 9761517
    [Abstract] [Full Text] [Related]

  • 36. Effects of cyclosporin A withdrawal on renal function and renal stimulation in liver transplant patients treated with triple-drug immunosuppression for over 2 years.
    Klompmaker IJ, Homan van der Heide JJ, Tegzess AM, Meijer S, Haagsma EB, Verwer R, Slooff MJ.
    Nephrol Dial Transplant; 1994 Sep 15; 9(11):1629-33. PubMed ID: 7870353
    [Abstract] [Full Text] [Related]

  • 37. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing.
    Bunke M, Sloan R, Brier M, Ganzel B.
    Transplantation; 1995 Feb 27; 59(4):537-40. PubMed ID: 7878758
    [Abstract] [Full Text] [Related]

  • 38. Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression.
    Pham H, Lemoine A, Salvucci M, Azoulay D, Frenoy N, Samuel D, Reynès M, Bismuth H, Debuire B.
    Liver Transpl Surg; 1998 Mar 27; 4(2):146-51. PubMed ID: 9516567
    [Abstract] [Full Text] [Related]

  • 39. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
    Hilbrands LB, Hoitsma AJ, Koene KA.
    Transplantation; 1996 Apr 15; 61(7):1038-46. PubMed ID: 8623182
    [Abstract] [Full Text] [Related]

  • 40. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant.
    Roberts CA, Stern DL, Radio SJ.
    Transplantation; 2002 Sep 27; 74(6):817-21. PubMed ID: 12364862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.